GlassScriptPhysician profile
Scott Richard Steinberg
NPI 1326433624
$564.40
in general payments reported to CMS, 2019-2025
11 companies · $38.30 in 2025
The $38.30 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $24.12 · 2022: $81.93 · 2023: $326 · 2024: $94.43 · 2025: $38.30.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $458.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $458.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $127.50 | 2023 | Inspire |
| Astrazeneca Pharmaceuticals LP | $106.26 | 2023 | Fasenra |
| Philips North America LLC | $74.48 | 2023 | |
| Intuitive Surgical, INC. | $62.96 | 2022 | |
| Inogen, INC. | $40.13 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $37.09 | 2024 | Dupixent |
| Glaxosmithkline, LLC. | $33.77 | 2024-2025 | Nucala |
| Boehringer Ingelheim Pharmaceuticals, INC. | $24.85 | 2024 | |
| United Therapeutics Corporation | $24.12 | 2021 | |
| Medtronic, INC. | $17.38 | 2023 | Illumisite |
| Jazz Pharmaceuticals INC. | $15.86 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Steinberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.